# Gyre Therapeutics, Inc.: Form SCHEDULE 13D/A, filed May 6, 2026

- Company: [Gyre Therapeutics, Inc.](/companies/gyre.md) (CIK 1124105)
- Form: SCHEDULE 13D/A
- Filed: 2026-05-06
- Accepted by EDGAR: May 7, 2026, 01:53 ET
- Period: not reported
- Accession: 0001140361-26-019388
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1124105/000114036126019388/xslSCHEDULE_13D_X02/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1124105/000114036126019388/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1124105/000114036126019388/xslSCHEDULE_13D_X02/primary_doc.xml

Filed May 6, 2026.
Source: SEC EDGAR, the filing index for accession 0001140361-26-019388. Last ingested by Listed: Oct 24, 2026, 15:05 ET. No prices; not investment advice.